Our news

Press releases

Press releases
Première inclusion dans l’étude MuControl
Posted on
Ad Scientiam est fier d’annoncer l’inclusion du premier patient au CRCM de Rouen dans l?étude clinique de validation de MuCopilot, ...
Press releases
Ad Scientiam est fier d?annoncer sa collaboration avec Abata Therapeutics
Posted on
Ad Scientiam est fier d?annoncer sa collaboration avec Abata Therapeutics Ad Scientiam est fier d?annoncer sa collaboration avec Abata Therapeutics ...
Press releases
Ad Scientiam et Kyowa Kirin unissent leurs forces
Posted on
Ad Scientiam et Kyowa Kirin unissent leurs forces Nous sommes ravis d’annoncer notre partenariat avec Kyowa Kirin pour innover dans ...
Press releases
Ad Scientiam et Ceres Brain Therapeutics unissent leurs forces pour développer des biomarqueurs digitaux innovants dans le déficit du transporteur de créatine.
Posted on
We are thrilled to announce that Ad Scientiam and Ceres Brain Therapeutics are launching a joint research program to develop new digital biomarkers for Creatine Transporter Deficiency Syndrome.
Press releases
L’étude clinique décentralisée ME&MGopen sur la myasthénie grave démarre avec succès.
Posted on
The ME&MGopen study has already recruited 165 patients in the USA and 11 in Canada. This innovative program is supported by Alexion, AstraZeneca Rare Disease.
Press releases
Ad Scientiam lance une étude internationale pour évaluer la progression du handicap dans la sclérose en plaques avec MSCopilot®
Posted on
Ad Scientiam, a global leader in digital biomarkers has announced the launch of MS-DETECT ...

Scientific publications

Scientific publications
Le Multiple Sclerosis Journal publie les résultats de notre étude PETALS sur l?impact socio-économique de la sclérose en plaques en France.
Posted on
Our study on the socio-economic impact of multiple sclerosis in France (PETALS) is in the Multiple Sclerosis Journal.
Scientific publications
Le British journal of dermatology présente les résultats de notre étude clinique sur les troubles du sommeil dans la dermatite atopique
Posted on
Le British journal of dermatology présente les résultats de notre étude clinique sur les troubles du sommeil dans la dermatite ...
Scientific publications
European Journal of Neurology présente les résultats de notre étude clinique sur MSCopilot®
Posted on
European Journal of Neurology presents the results of our clinical study on MSCopilot®

Awards and Selections

Awards and Selections
Ad Scientiam lauréat du French Healthcare Booster Germany 2023 !
Posted on
Ad Scientiam was selected by a jury of French and German experts made up of specialists from the German medtech market ...
Awards and Selections
Ad Scientiam soutenu par le programme PM?up de la Région Ile-de-France
Posted on
Ad Scientiam was selected by the Ile-de-France Regional Council for the PM’up program.
Awards and Selections
Le développement de MSCopilot® soutenu par le Programme Innov?up Leader PIA de la Région Ile-de-France
Posted on
The development of MSCopilot® has been selected to benefit from innovation aid under the Innov'up Leader PIA scheme
See all our awards & selections

Nos prises de parole récentes

Nos prises de parole récentes
Association et agreement pour une comparaison de méthodes, Quelle est la méthode la plus appropriée dans les études cliniques ?
Posted on
Association and agreement for a comparison of methods, What is the most appropriate method in clinical studies?
Nos prises de parole récentes
Avantages des représentations en catégories parallèles
Posted on
Advantages of parallel category representations April 11, 2022 The transformation of raw data and the choice of representation ...
Nos prises de parole récentes
Comment 8 années ont changé notre logo
Posted on
How 8 years have changed our logo March 30, 2022 After 8 years of existence, our old logo gives way ...
Nos prises de parole récentes
Chiffres clés 2021
Posted on
Key figures 2021 March 15, 2022 Ad Scientiam, leader in digital biomarkers, continues its strong growth and the year 2021 has ...
Nos prises de parole récentes
Comment construire un moteur de recommandation d’activité physique ?
Posted on
How to build a physical activity recommendation engine March 15, 2022 Numerous studies report that high levels ...
Nos prises de parole récentes
Comment rendre intelligible des notions complexes comme l?écoulement du temps ?
Posted on
How to make complex notions such as the flow of time intelligible? Time is by nature cyclical, ...

Our calls for volunteers

Participate in medical research by volunteering for research projects conducted by Ad Scientiam.

Our calls for volunteers
Étude clinique sur les troubles dépressifs – vague 2
Posted on
Depressive Disorders Clinical Study - Wave 2 October 2020 Status: recruiting in progress. We are recruiting male ...
Our calls for volunteers
Enquête sur les impacts de la sclérose en plaques
Posted on
Multiple Sclerosis Impact Survey October 2020 Status: project completed The purpose of this study is to measure ...
Our calls for volunteers
Étude clinique sur les troubles dépressifs – vague 1
Posted on
Depressive Disorders Clinical Study - Wave 1 June 2020 Status: recruiting in progress. We are recruiting male ...
Our calls for volunteers
Projet d?intelligence artificielle sur la recommandation d?activité physique
Posted on
Artificial intelligence project on physical activity recommendation June 2020 Status : project completed. Ad Scientiam wants to use artificial intelligence to recommend ...
Ad Scientiam is proud to announce its collaboration with Abata Therapeutics Read the article
en_USEnglish
fr_FRFrench en_USEnglish